Libtayo
The RxWiki Digital Pharmacist stamp of approval lets you know that this content has been created and reviewed by a licensed pharmacist.
Libtayo is used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma. The most common side effects of Libtayo include tiredness, rash and diarrhea.
Libtayo Overview
Libtayo is a prescription medication used to treat metastatic cutaneous squamous cell carcinoma (CSCC).
Libtayo belongs to a group of drugs called monoclonal antibodies. It works by blocking a protein called PD-1 on certain immune cells called T-cells. This protein helps cancer cells avoid being found and destroyed by the body’s immune system. Blocking the PD-1 protein helps the immune system recognize the cancer cells and attack them.
This medication is available in an injectable form to be given directly into a vein (IV) by a healthcare professional.
Common side effects of Libtayo include tiredness, rash, and diarrhea.
How was your experience with ?
Libtayo Drug Class
Libtayo is part of the drug class: